Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04712981 · ClinicalTrials.gov registry record · NA

Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder

A NA study of Opioid Use Disorder, sponsored by University of California, Irvine.

Active
Registry status
NA
Development phase
640
Enrollment target
1
Study location

NCT04712981 is a NA study of Opioid Use Disorder that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 640 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04712981, a NA study of Opioid Use Disorder, is active but no longer recruiting, sponsored by University of California, Irvine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
640 participants
Enrollment target
1
Study location

Study Summary

In a randomized controlled trial, with 3, 6-month and 1-year follow-up, this application aims to explore whether and how the HOPE intervention can be adapted to increase MOUD uptake among OUD patients, assess the effectiveness of using HOPE to increase MOUD requests, and analyze online community data to improve future intervention implementation and sustainability.

Conditions Studied

Interventions

  • BEHAVIORAL HOPE

Study Locations (1)

California

  • University of California, Irvine - Irvine

Trial Details

FieldValue
Enrollment Target 640 participants
Start Date 2021-04-29
Est. Completion 2026-05
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT04712981

The ClinicalTrials.gov registry entry for NCT04712981 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 640 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (86% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which HOPE is the first listed.

NCT04712981 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04712981 about?

NCT04712981 is a clinical study titled "Adapting the HOPE Online Support Intervention to Increase Uptake of Medications for Opioid Use Disorder". In a randomized controlled trial, with 3, 6-month and 1-year follow-up, this application aims to explore whether and how the HOPE intervention can be adapted to increase MOUD uptake among OUD patients, assess the effectiveness of using HOPE to increase MOUD requests, and analyze online community dat...

What is the current status of trial NCT04712981?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 640 participants. The study started on 2021-04-29. Estimated completion is 2026-05.

What conditions does trial NCT04712981 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT04712981?

The interventions under investigation include: HOPE (BEHAVIORAL).

Who is sponsoring clinical trial NCT04712981?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04712981 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.